On Days 2, 7, and 14, samples treated with 80 mM K+ (denoted AD-80K) had significantly lower LPL expression compared to untreated AD samples (decrease of 50.7-fold, 219.7-fold, and 43.5-fold, respectively, p<0.007, Fig. 3). This evidence concerns the gene LPL and Alzheimer disease.